AI assistant
Sending…
HARVARD BIOSCIENCE INC — Director's Dealing 2020
Apr 15, 2020
34975_dirs_2020-04-15_339cc926-adb8-4eea-aa87-d299a2a14a9b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2020-04-13
Reporting Person: Steele Susan M. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-04-13 | Non-Qualified Stock Option (right to buy) | $2.48 | A | 115900 | Acquired | 2030-04-13 | Common Stock, par value $0.01 per share (115900) | Direct |
Footnotes
F1: The options vest in three equal installments on April 13, 2021, April 13, 2022 and April 13, 2023.
More from HARVARD BIOSCIENCE INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 23
Major Shareholding Notification
2026
Mar 23
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 17
Regulatory Filings
2026
Mar 17